Crestline Management’s Aprea Therapeutics APRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,441	Closed	-$36K	–	208
2022 Q2	$36K	Sell	2,441 -32	-1%	-$472	﹤0.01%	218
2022 Q1	$92K	Buy	+2,473	New	+$92K	0.01%	242